# This is for informational purposes only. For medical advice or diagnosis, consult a professional. The US Food and Drug Administration (US FDA) has restricted imports of 11 products made at Viatris' facility in India after an inspection revealed violations of federal requirements. The affected products will not be accepted into the US until the warning letter is lifted. Exceptions, subject to certain conditions, have been made for four products due to shortage concerns. Viatris said it is working on corrective actions and has engaged independent experts to address the FDA's concerns. The company is committed to ensuring the quality and safety of its products. https://www.verifiedmarketreports.com/product/lionaes-mane-mushroom-extract-market-size-and-forecast/ https://www.verifiedmarketreports.com/product/gas-injected-enhanced-oil-recovery-market/ https://www.verifiedmarketreports.com/product/juice-concentrates-market/ https://www.verifiedmarketreports.com/product/commercial-vehicle-remote-diagnostics-market/ https://vlms-48406098.hubspotpagebuilder.com/blog/south-korea-nor-flash-market-by-application https://vlms-48406098.hubspotpagebuilder.com/blog/south-korea-nor-flash-for-cars-market-by-application https://vlms-48406098.hubspotpagebuilder.com/blog/south-korea-nor-flash-for-automotive-market-by-application https://vlms-48406098.hubspotpagebuilder.com/blog/south-korea-no-residue-security-label-market-by-application https://vlms-48406098.hubspotpagebuilder.com/blog/south-korea-norepinephrine-drug-market-by-application